Amgen sees no bone safety concerns around experimental obesity drug-March 2024-www.financetom.com

Amgen sees no bone safety concerns around experimental obesity drug

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Amgen sees no bone safety concerns around experimental obesity drug

Nov 13, 2024 2:28 AM

Nov 13 (Reuters) - Amgen ( AMGN ) said on Wednesday it

does not see any bone safety concerns around the use of its

experimental obesity drug, a day after data from an early-stage

study dragged its stock 7% lower.

(Reporting by Leroy Leo in Bengaluru; Editing by Shinjini

Ganguli)

Previous page： Vistra Unusual Options Activity Next page： Update: FSD Pharma $2 Million Arbitration Award Upheld by Federal Court Against Former CEO

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Vistra Unusual Options Activity

Jun 28, 2024

Deep-pocketed investors have adopted a bearish approach towards Vistra ( VST ) , and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in VST usually suggests something big is about to happen. We gleaned this information from...

Update: FSD Pharma $2 Million Arbitration Award Upheld by Federal Court Against Former CEO

Jun 28, 2024

03:01 PM EDT, 06/28/2024 (MT Newswires) -- (Updates with attempt to reach out to Raza Bokhari.) FSD Pharma's ( HUGE ) former board chairman and chief executive owes more than $2.2 million, plus interest, to the company, after a federal court confirmed a November 2022 arbitration award. Former FSD Pharma ( HUGE ) CEO Raza Bokhari was fired in July...

BlackRock shareholders vote to keep company directors in place in fight with Saba

Jun 28, 2024

NEW YORK (Reuters) - BlackRock ( BLK ) won a fight with hedge fund manager Boaz Weinstein this week when shareholders voted at four of its closed-end funds to keep the asset manager's directors in place and retain it as the manager, new data released on Friday show. Weinstein's Saba Capital Management, a large owner in BlackRock's ( BLK )...

Microsoft hit with EU antitrust charge over Teams app, risks hefty fine

Jun 28, 2024

(This June 25 story has been corrected to say 'eleven years,' not 'two decades,' in paragraph 2, and 'in the previous decade,' not 'two decades ago,' in paragraph 6) By Foo Yun Chee BRUSSELS (Reuters) - Microsoft faces a hefty antitrust fine after the European Commission on Tuesday accused it of illegally linking its chat and video app Teams with...